The 1.875% convertible senior notes are due 2030

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Integer Holdings Corporation of $1 billion aggregate principal amount of its 1.875% convertible senior notes due 2030, which included $125 million principal amount of notes pursuant to the exercise in full of the initial purchasers’ option to purchase additional notes. In addition, Davis Polk advised the counterparties to the capped call transactions entered into in connection with the offering, and also advised the existing counterparties to the existing capped call transactions entered into in connection with the issuance of Integer Holdings Corporation’s 2.125% convertible senior notes due 2028 with respect to the partial unwind of such existing capped call transactions.

Integer Holdings Corporation, headquartered in Plano, Texas, is among the world’s largest medical device contract development and manufacturing organizations, serving the cardiac rhythm management, neuromodulation, and cardio and vascular markets. As a strategic partner of choice to medical device companies and original equipment manufacturers, Integer is committed to enhancing the lives of patients worldwide by providing innovative, high-quality products and solutions. Integer is listed on the New York Stock Exchange under the symbol “ITGR.”

The Davis Polk capital markets team included partner Derek Dostal and associates Kanger Jin and Joshua L. Bi. The equity derivatives team included partner Mark M. Mendez, counsel Gregory E. Marchesini and associates Alexander S. Pettingell and Ji Hwan Kim. Partner Lucy W. Farr provided tax advice. Partner Matthew J. Bacal provided intellectual property advice. All members of the Davis Polk team are based in the New York office.

Copy link to share post